LivaNova partners with Verily for RECOVER clinical study

The study will analyse the effectiveness of LivaNova’s Vagus Nerve Stimulation Therapy for Difficult-to-Treat Depression (DTD). Credit: Eric Ward on Unsplash.



  • The study will analyse the effectiveness of LivaNova’s Vagus Nerve Stimulation Therapy for Difficult-to-Treat Depression (DTD).